tibolone has been researched along with tamoxifen in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (10.71) | 18.2507 |
| 2000's | 18 (64.29) | 29.6817 |
| 2010's | 7 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dalvie, D; Loi, CM; Smith, DA | 1 |
| de Chambine, S; Decroix, Y; Gompel, A; Jacob, D; Mimoun, M; Poitout, P; Rostene, W | 1 |
| Christiansen, C | 1 |
| Brouillet, JP; Maudelonde, T; Pujol, P | 1 |
| Galid, A; Kubista, E; Seifert, M | 1 |
| Ang, WC; Farrell, E; Vollenhoven, B | 1 |
| Baker, RS; Clark, KE; Kopernik, G; Mershon, JL; Zoma, WD | 1 |
| Bundred, N; Fentiman, IS; Foidart, JM; Helmond, FA; Kroiss, R; Kubista, E; Mol-Arts, M; Rymer, J | 1 |
| Mijatovic, V; van der Mooren, MJ; Vogelvang, TE | 1 |
| Czerny, B; Juzyszyn, Z; Myśliwiec, Z; Pawlik, A; Teister, M | 1 |
| Albertazzi, P; Richmond, I; Sharma, S | 1 |
| Herrington, DM; Lakoski, SG | 1 |
| Baber, R; Hickey, M; Kwik, M | 1 |
| Franke, HR; Vermes, I; Werner, HM | 1 |
| Bredakis, N; Dimitrakakis, C; Gaki, V; Keramopoulos, A; Keramopoulos, D; Vourli, G | 1 |
| Athayde, C; Correia, T; Coutinho, E; Freitas, LA; Maia, H | 1 |
| Kluft, C | 1 |
| Beckmann, MW; Bundred, NJ; Egberts, J; Foidart, JM; Kenemans, P; Kubista, E; Planellas, J; Sismondi, P; van Os, S; Vassilopoulou-Sellin, R; von Schoultz, B; Yip, CH | 1 |
| Biberoglu, K; Celik, HH; Gürsoy, RH; Keskin, PO; Nas, T; Sargon, MF | 1 |
| Neves-E-Castro, M | 1 |
| Bentolila, J; Boisserie-Lacroix, M; Bouzgarrou, M; Cavagni, P; Laumonier, H; Lebiez-Michel, N; Trillaud, H | 1 |
| Fu, R; Griffin, JC; Humphrey, L; Nelson, HD; Nygren, P; Smith, ME | 1 |
| Arun, B; Brown, PH; Castiglione, M; Cuzick, J; DeCensi, A; Dunn, B; Forbes, JF; Glaus, A; Howell, A; Vogel, V; von Minckwitz, G; Zwierzina, H | 1 |
| Biglia, N; Egberts, J; Kenemans, P; Kimmig, R; Kubista, E; Moggio, G; Mol-Arts, M; Mulder, R; Planellas, J; Sismondi, P | 1 |
| Cucinella, L; Nappi, RE | 1 |
| Castelo-Branco, C; Currie, H; Mijatovic, V; Nappi, RE; Palacios, S; Rees, M; Simon, J | 1 |
| Briarava, M; Mocellin, S; Nitti, D; Pilati, P | 1 |
| Altwerger, G; Black, J; Feinberg, J; Menderes, G; Ratner, E; Whicker, M | 1 |
15 review(s) available for tibolone and tamoxifen
| Article | Year |
|---|---|
[Action of SERM and SAS (tibolone) on breast tissue].
Topics: Antineoplastic Agents, Hormonal; Breast; Breast Neoplasms; Estrogen Antagonists; Female; Humans; Neoplasms, Hormone-Dependent; Norpregnenes; Receptors, Estrogen; Tamoxifen | 1999 |
[Anti-estrogens, selective estrogen receptor modulators (SERM), tibolone: modes of action].
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Estrogen Receptor Modulators; Female; Humans; Norpregnenes; Selective Estrogen Receptor Modulators; Tamoxifen | 1999 |
Effect of hormone replacement therapies and selective estrogen receptor modulators in postmenopausal women with uterine leiomyomas: a literature review.
Topics: Animals; Disease Models, Animal; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen; Uterine Neoplasms | 2001 |
Hormone replacement therapy, selective estrogen receptor modulators, and tissue-specific compounds: cardiovascular effects and clinical implications.
Topics: Aging; Animals; Arteriosclerosis; Cardiovascular Diseases; Cardiovascular System; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen | 2004 |
Effects of oestrogen receptor-active compounds on lipid metabolism.
Topics: Antineoplastic Agents; Bone Density Conservation Agents; Female; Humans; Lipid Metabolism; Male; Norpregnenes; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen | 2005 |
Therapy for menopausal symptoms during and after treatment for breast cancer : safety considerations.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Case-Control Studies; Clonidine; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Health Behavior; Hot Flashes; Humans; Menopause; Norpregnenes; Paroxetine; Personal Health Services; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Tamoxifen | 2005 |
Effects of hormone treatment on hemostasis variables.
Topics: Administration, Oral; Administration, Topical; Dose-Response Relationship, Drug; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Hemostasis; Humans; Inflammation; Norpregnenes; Progestins; Raloxifene Hydrochloride; Tamoxifen; Venous Thromboembolism | 2007 |
Association of ovarian and uterine cancers with postmenopausal hormonal treatments.
Topics: Estrogen Replacement Therapy; Estrogens; Female; Humans; Norpregnenes; Ovarian Neoplasms; Postmenopause; Progestins; Raloxifene Hydrochloride; Risk Factors; Tamoxifen; Uterine Neoplasms | 2008 |
[Hormones and mammographic breast density].
Topics: Adult; Aged; Biopsy; Breast; Breast Neoplasms; Contraceptive Agents, Female; Diagnosis, Differential; Estrogen Replacement Therapy; Female; Gonadal Steroid Hormones; Hormones; Humans; Intrauterine Devices; Levonorgestrel; Mammography; Menopause; Menstrual Cycle; Middle Aged; Norpregnenes; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Selective Estrogen Receptor Modulators; Sensitivity and Specificity; Tamoxifen | 2008 |
Systematic review: comparative effectiveness of medications to reduce risk for primary breast cancer.
Topics: Breast Neoplasms; Endometrial Neoplasms; Estrogen Receptor Modulators; Female; Fractures, Bone; Humans; Norpregnenes; Raloxifene Hydrochloride; Stroke; Tamoxifen; Thromboembolism | 2009 |
Preventive therapy for breast cancer: a consensus statement.
Topics: Anastrozole; Androstadienes; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Consensus Development Conferences as Topic; Diphosphonates; Estrogen Receptor Modulators; Expert Testimony; Female; Fenretinide; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metformin; Nitriles; Norpregnenes; Piperidines; Premenopause; Pyrrolidines; Raloxifene Hydrochloride; Retinoids; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes; Triazoles | 2011 |
Advances in pharmacotherapy for treating female sexual dysfunction.
Topics: Buspirone; Clinical Trials, Phase III as Topic; Estrogens; Female; Humans; Menopause; Norpregnenes; Piperazines; Purines; Selective Estrogen Receptor Modulators; Sexual Behavior; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Sildenafil Citrate; Sulfonamides; Tamoxifen; Testosterone | 2015 |
Update on management of genitourinary syndrome of menopause: A practical guide.
Topics: Atrophy; Complementary Therapies; Estrogen Replacement Therapy; Estrogens; Female; Humans; Laser Therapy; Menopause; Norpregnenes; Quality of Life; Selective Estrogen Receptor Modulators; Sexuality; Syndrome; Tamoxifen; Vagina; Vulva | 2015 |
Breast Cancer Chemoprevention: A Network Meta-Analysis of Randomized Controlled Trials.
Topics: Adult; Aged; Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Middle Aged; Norpregnenes; Piperidines; Postmenopause; Primary Prevention; Pyrrolidines; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Assessment; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes | 2016 |
Management of sexuality, intimacy, and menopause symptoms in patients with ovarian cancer.
Topics: Administration, Topical; Anabolic Agents; Body Image; Cognitive Behavioral Therapy; Depression; Estrogen Antagonists; Estrogens; Fatigue; Female; Hormone Replacement Therapy; Humans; Lubricants; Menopause, Premature; Norpregnenes; Ovarian Neoplasms; Pelvic Floor Disorders; Physical Therapy Modalities; Phytotherapy; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Sexuality; Tamoxifen; Testosterone | 2017 |
4 trial(s) available for tibolone and tamoxifen
| Article | Year |
|---|---|
The effect of tibolone in postmenopausal women receiving tamoxifen after surgery for breast cancer: a randomised, double-blind, placebo-controlled trial.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Chemotherapy, Adjuvant; Double-Blind Method; Endometrium; Estrogen Antagonists; Estrogen Receptor Modulators; Female; Hot Flashes; Humans; Hyperhidrosis; Lipids; Mammography; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Pilot Projects; Postmenopause; Tamoxifen | 2005 |
Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Mammography; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Postmenopause; Prospective Studies; Tamoxifen | 2005 |
Safety of tibolone in the treatment of vasomotor symptoms in breast cancer patients--design and baseline data 'LIBERATE' trial.
Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Autonomic Nervous System Diseases; Bone Density; Breast Neoplasms; Double-Blind Method; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Norpregnenes; Quality of Life; Survival Analysis; Tamoxifen; Treatment Outcome; Vasomotor System | 2007 |
Effects of tibolone on climacteric symptoms and quality of life in breast cancer patients--data from LIBERATE trial.
Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Atrophic Vaginitis; Breast Neoplasms; Climacteric; Contraindications; Estrogen Receptor Modulators; Female; Hot Flashes; Humans; Intention to Treat Analysis; Longitudinal Studies; Middle Aged; Norpregnenes; Postmenopause; Quality of Life; Surveys and Questionnaires; Tamoxifen | 2011 |
9 other study(ies) available for tibolone and tamoxifen
| Article | Year |
|---|---|
Which metabolites circulate?
Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations | 2013 |
Sex steroid analogs.
Topics: Animals; Bone Resorption; Breast Neoplasms; Estrogen Antagonists; Female; Gonadal Steroid Hormones; Hormones; Humans; Norpregnenes; Osteoporosis, Postmenopausal; Pyrrolidines; Raloxifene Hydrochloride; Receptors, Estrogen; Risk; Tamoxifen | 1999 |
The oestrogen receptor and its selective modulators in gynaecological oncology.
Topics: Antineoplastic Agents, Hormonal; Cinnamates; Estrogen Antagonists; Female; Genital Neoplasms, Female; Humans; Norpregnenes; Piperidines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Stilbenes; Tamoxifen; Thiophenes; Toremifene | 2000 |
Differential effects of selective estrogen receptor modulators and estrogens on mammary blood flow in the ovine.
Topics: Animals; Blood Flow Velocity; Blood Pressure; Estradiol; Estrogens; Estrogens, Conjugated (USP); Female; Heart Rate; Kinetics; Mammary Glands, Animal; Norpregnenes; Ovariectomy; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Sheep; Tamoxifen | 2002 |
Effect of tamoxifen, raloxifen and tibolon on bile components in ovariectomized rats.
Topics: Animals; Bile; Bile Acids and Salts; Calcium; Chlorides; Cholesterol; Female; Norpregnenes; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Wistar; Tamoxifen | 2005 |
Vaginal polyps and hormones--is there a link? A case series.
Topics: Adult; Aged; Aged, 80 and over; Androgen Antagonists; Estrogen Antagonists; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norpregnenes; Polyps; Postmenopause; Premenopause; Retrospective Studies; Tamoxifen; Vaginal Diseases | 2006 |
Apoptosis and proliferation in breast cancer cells, cultured in vitro: effects of SERMs.
Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Contraceptive Agents, Female; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Humans; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Norpregnenes; Progesterone; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Tumor Cells, Cultured | 2005 |
Cyclooxygenase-2 expression in endometrial polyps during menopause.
Topics: Cyclooxygenase 2; Endometrium; Estrogen Receptor Modulators; Estrogens, Conjugated (USP); Female; Gonadal Steroid Hormones; Humans; Ki-67 Antigen; Menopause; Norpregnenes; Polyps; Tamoxifen; Uterine Diseases | 2005 |
Ultrastructure study of postmenopausal endometria of tibolone, conjugated estrogen + medroxyprogesterone acetate and tamoxifen users.
Topics: Aged; Case-Control Studies; Endometrium; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Tamoxifen | 2007 |